Save time and get answers to complex questions with AI chat
Excipients list used in dexamethasone creams?When will latisse patent expire?What's the recommended schedule for lurbinectedin side effect checks?Combivent inhaler hfc 152a patents?Bivalirudin manufacturer?
See the DrugPatentWatch profile for Prolia
Prolia is made by Amgen, the U.S. biotechnology company.
Prolia is associated with Amgen’s brand and intellectual property.
DrugPatentWatch.com tracks brands, manufacturers, and patent information and can be used to confirm details about Prolia and related IP activity. [1]
Prolia (denosumab) is used for conditions involving bone loss, including osteoporosis in certain patients and other specified bone-related indications.
After approvals, other firms may become involved through manufacturing, distribution, or later biosimilar competition, but the branded product is tied to the original developer/holder described above. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Prolia :